Translational Research Beyond Approval: A Two-Stage Ethics Review

American Journal of Bioethics 10 (8):W1-W3 (2010)
  Copy   BIBTEX

Abstract

Commentators on the ethics of translational research find it morally problematic. Types of translational research are said to involve questionable benefits, special risks, additional barriers to informed consent, and severe conflicts of interest. Translational research conducted on the global poor is thought to exploit them and increase international disparities. Some commentators support especially stringent ethical review. However, such concerns are grounded only in pre-approval translational research. Whether or not T1 has these features, translational research beyond approval is unlikely to and, when conducted on the global poor, may support development. Therefore, insofar as T1 is morally problematic, and no independent objections to T2 exist, the ethics of translational research is diverse: while some translational research is problematic, some is not. Funding and oversight should reflect this diversity, and T2 should be encouraged, particularly when conducted among the global poor.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 97,319

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2010-08-11

Downloads
47 (#367,660)

6 months
17 (#242,816)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Nir Eyal
Harvard University

Citations of this work

No citations found.

Add more citations

References found in this work

Rethinking informed consent in bioethics.Neil C. Manson - 2007 - New York: Cambridge University Press. Edited by Onora O'Neill.
The Diverse Ethics of Translational Research.Neema Sofaer & Nir Eyal - 2010 - American Journal of Bioethics 10 (8):19-30.
AZT Trials and Tribulations.Robert A. Crouch & John D. Arras - 1998 - Hastings Center Report 28 (6):26-34.
Harm, ethics committees and the gene therapy death.Julian Savulescu - 2001 - Journal of Medical Ethics 27 (3):148-150.

View all 18 references / Add more references